Stephens Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4M | Buy |
53,960
+42,335
| +364% | +$7.96M | 0.12% | 175 |
|
|
2026
Q1 | $2.29M | Sell |
11,625
-453
| -4% | -$87.3K | 0.03% | 448 |
|
|
2025
Q4 | $2.22M | Buy |
12,078
+369
| +3% | +$64.7K | 0.03% | 455 |
|
|
2025
Q3 | $1.8M | Sell |
11,709
-39
| -0.3% | -$5.9K | 0.02% | 512 |
|
|
2025
Q2 | $1.64M | Buy |
11,748
+13
| +0.1% | +$1.82K | 0.02% | 507 |
|
|
2025
Q1 | $1.73M | Sell |
11,735
-759
| -6% | -$110K | 0.03% | 503 |
|
|
2024
Q4 | $1.64M | Sell |
12,494
-680
| -5% | -$95.2K | 0.02% | 489 |
|
|
2024
Q3 | $2.05M | Sell |
13,174
-118
| -0.9% | -$19K | 0.03% | 440 |
|
|
2024
Q2 | $2.07M | Buy |
13,292
+310
| +2% | +$46.6K | 0.03% | 424 |
|
|
2024
Q1 | $1.76M | Sell |
12,982
-213
| -2% | -$28.2K | 0.03% | 454 |
|
|
2023
Q4 | $1.78M | Buy |
13,195
+2,037
| +18% | +$265K | 0.03% | 419 |
|
|
2023
Q3 | $1.51M | Buy |
11,158
+507
| +5% | +$69.2K | 0.03% | 439 |
|
|
2023
Q2 | $1.52M | Buy |
10,651
+16
| +0.2% | +$2.35K | 0.03% | 445 |
|
|
2023
Q1 | $1.48M | Buy |
10,635
+312
| +3% | +$42K | 0.03% | 459 |
|
|
2022
Q4 | $1.4M | Buy |
10,323
+576
| +6% | +$72.2K | 0.03% | 451 |
|
|
2022
Q3 | $1.07M | Sell |
9,747
-203
| -2% | -$25.8K | 0.02% | 506 |
|
|
2022
Q2 | $1.31M | Sell |
9,950
-84
| -0.8% | -$11K | 0.03% | 461 |
|
|
2022
Q1 | $1.33M | Sell |
10,034
-112
| -1% | -$13.4K | 0.02% | 519 |
|
|
2021
Q4 | $1.18M | Sell |
10,146
-18
| -0.2% | -$2.12K | 0.02% | 578 |
|
|
2021
Q3 | $1.22M | Buy |
10,164
+1,811
| +22% | +$211K | 0.02% | 589 |
|
|
2021
Q2 | $1M | Buy |
8,353
+374
| +5% | +$41K | 0.02% | 662 |
|
|
2021
Q1 | $793K | Sell |
7,979
-1,145
| -13% | -$115K | 0.01% | 695 |
|
|
2020
Q4 | $912K | Buy |
9,124
+38
| +0.4% | +$4.03K | 0.02% | 615 |
|
|
2020
Q3 | $996K | Buy |
9,086
+1,070
| +13% | +$119K | 0.02% | 555 |
|
|
2020
Q2 | $848K | Sell |
8,016
-66
| -0.8% | -$6.82K | 0.02% | 563 |
|
|
2020
Q1 | $722K | Sell |
8,082
-304
| -4% | -$28.6K | 0.02% | 555 |
|
|
2019
Q4 | $836K | Sell |
8,386
-522
| -6% | -$49.1K | 0.02% | 597 |
|
|
2019
Q3 | $794K | Sell |
8,908
-8,845
| -50% | -$767K | 0.02% | 619 |
|
|
2019
Q2 | $1.47M | Sell |
17,753
-2,413
| -12% | -$189K | 0.03% | 467 |
|
|
2019
Q1 | $1.63M | Sell |
20,166
-28,267
| -58% | -$2.23M | 0.04% | 451 |
|
|
2018
Q4 | $3.68M | Sell |
48,433
-7,666
| -14% | -$599K | 0.1% | 234 |
|
|
2018
Q3 | $4.44M | Sell |
56,099
-45,377
| -45% | -$3.43M | 0.11% | 224 |
|
|
2018
Q2 | $7.13M | Buy |
+101,476
| New | +$7.3M | 0.22% | 112 |
|
|
2014
Q1 | – | Sell |
-98,772
| Closed | -$5.86M | – | 809 |
|
|
2013
Q4 | $5.86M | Sell |
98,772
-10,415
| -10% | -$566K | 0.29% | 50 |
|
|
2013
Q3 | $5.67M | Sell |
109,187
-15,849
| -13% | -$796K | 0.31% | 46 |
|
|
2013
Q2 | $5.91M | Buy |
+125,036
| New | +$6.37M | 0.33% | 46 |
|
Other funds holding AZN
EP
IA
Stephens Inc's AZN Position: Q2 2026 in Review
Stephens Inc increased its AstraZeneca (AZN) stake by 364% in Q2 2026, buying an estimated $7.96M and bringing the position to 53,960 shares worth $10.4M. The position accounts for 0.12% of the portfolio, ranked #175.
Stephens Inc first reported a position in AZN in Q2 2013 and has held it in 36 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Stephens Inc held 53,960 shares of AstraZeneca worth $10.4M as of Q2 2026.
- Stephens Inc bought 42,335 AstraZeneca shares in Q2 2026, an estimated $7.96M.
- AstraZeneca made up 0.12% of Stephens Inc's portfolio in Q2 2026, its #175 holding.
- Stephens Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 36 quarters since.
- 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.